Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Biological, Radiation
  • Participants: 80
  • Start Date: May 27, 2021
Phase I/II Trial of Anti-CTLA4-NF mAb (BMS-986218) in Combination With Nivolumab and Hypofractionated Stereotactic Radiation Therapy in Patients With Advanced Solid Malignancies
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 20
  • Start Date: September 30, 2020
A Phase 1b, Open-Label Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 1000
  • Start Date: August 30, 2020
Precise Diagnosis, Treatment and Prognostic Evaluation of Complicated Adrenal Tumor Diseases
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug, Procedure
  • Participants: 30
  • Start Date: August 27, 2020
PET Biodistribution Study of 68Ga-FAPI-46 in Patients With Different Malignancies: An Exploratory Biodistribution Study With Histopathology Validation
Clinical Trial
  • Status: Active, not recruiting
  • Phase: N/A
  • Intervention Type: Procedure
  • Participants: 6
  • Start Date: August 27, 2020
Clinical Trial Protocol of Primary Study on Efficacy and Safety of Telesurgery for Patients With Tumors of the Urinary System Using Chinese Independently Developed MicroHand Surgical Robot System
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Biological
  • Participants: 60
  • Start Date: July 23, 2020
A Phase 1/2 Trial of a Novel Therapeutic Vaccine (EO2401) in Combination With Immune Check Point Blockade, for Treatment of Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
Clinical Trial
  • Status: Recruiting
  • Participants: 300
  • Start Date: June 25, 2020
Natural History Study of Children and Adults With Adrenocortical Cancer
Clinical Trial
  • Status: Active, not recruiting
  • Participants: 1000
  • Start Date: April 20, 2020
Retrospective Study of Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 43
  • Start Date: April 1, 2020
Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 30
  • Start Date: September 26, 2019
Cone-beam Computed Tomography Guided Percutaneous Cryoablation of Bone Metastases From Endocrine Tumors
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 37
  • Start Date: June 4, 2019
Phase II Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable/Metastatic Adrenocortical Carcinoma
Clinical Trial
  • Status: Recruiting
  • Participants: 10000
  • Start Date: January 28, 2019
Natural History and Biospecimen Acquisition Study for Children and Adults With Rare Solid Tumors
Showing 1-12 of 37